Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 9, 2026

A Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies
09:32

A Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies

Published on: September 23, 2014

Tissue microarrays: emerging standard for biomarker validation.

Saima Hassan1, Cristiano Ferrario, Aline Mamo

  • 1Departments of Oncology and Surgery, Segal Cancer Center, 3755 Cote Ste Catherine Road, Montreal, Quebec, Canada H3T 1E2.

Current Opinion in Biotechnology
|December 7, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of a Canadian real-world cohort of metastatic castration-sensitive prostate cancer patients stratified by early PSA nadir.

Future oncology (London, England)·2026
Same author

Sequencing PARP inhibitors in breast cancer: lessons learned and emerging insights.

NPJ breast cancer·2026
Same author

Estrogen-mediated NF-κB blockade enables breast cancer sensitivity to oncolytic VSV virotherapy.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Trends in breast reconstruction for BRCA1/2, PALB2 and other high penetrance germline pathogenic variant carriers undergoing risk reducing mastectomy.

Familial cancer·2026
Same author

ATR and PKMYT1 Inhibition Resensitizes a Subset of TNBC Patient-Derived Models to Carboplatin, Inducing Mitotic Catastrophe.

Cancer research communications·2026
Same author

ASO Visual Abstract: Impact of Ethnicity on the Uptake of Risk-Reducing Mastectomy in Unaffected BRCA1/2 and PALB2 Carriers in Canada.

Annals of surgical oncology·2026

Tissue microarrays (TMAs) enable high-throughput biomarker validation in clinical samples. These arrays are crucial for translating laboratory findings into clinical applications, despite some limitations.

Area of Science:

  • Biotechnology
  • Molecular Pathology
  • Clinical Diagnostics

Background:

  • Hundreds of biomarkers require validation using well-annotated clinical samples.
  • DNA microarrays are widely used, necessitating efficient validation methods.

Purpose of the Study:

  • To highlight the utility of Tissue Microarrays (TMAs) for high-throughput biomarker analysis.
  • To discuss the role of TMAs in translating laboratory data to clinical practice.

Main Methods:

  • Tissue microarrays (TMAs) facilitate DNA, RNA, and protein expression analysis on numerous clinical samples.
  • Development of automated methods for TMA analysis and optimization of cell microarrays and frozen tissue TMAs.

Main Results:

  • TMAs are an increasingly validated tool for assessing diagnostic, prognostic, and therapy-related markers.

More Related Videos

Production of Tissue Microarrays, Immunohistochemistry Staining and Digitalization Within the Human Protein Atlas
09:08

Production of Tissue Microarrays, Immunohistochemistry Staining and Digitalization Within the Human Protein Atlas

Published on: May 31, 2012

Related Experiment Videos

Last Updated: Jul 9, 2026

A Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies
09:32

A Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies

Published on: September 23, 2014

Production of Tissue Microarrays, Immunohistochemistry Staining and Digitalization Within the Human Protein Atlas
09:08

Production of Tissue Microarrays, Immunohistochemistry Staining and Digitalization Within the Human Protein Atlas

Published on: May 31, 2012

  • Despite limitations in scoring subjectivity and sample representativeness, TMAs are vital for biomarker studies.

    • Conclusions:

    • Tissue microarrays are indispensable for the rapid translation of biomarker research into clinical applications.
    • TMAs offer a high-throughput solution for biomarker validation in large patient cohorts.